Peetz Christopher sold MIRM
August 7, 2025 · Form 4 insider transaction
Peetz Christopher sold 40,000 shares of Mirum Pharmaceuticals, Inc. at $55.25 per share, a transaction worth $2.21M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
40,000
Price
$55.25
Total value
$2.21M
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 7, 2025
Filing dateAugust 8, 2025
Shares owned after138,641
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024.; The weighted average sale price for the transaction reported was $55.251022, and the range of prices were between $55.25 and $55.485. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.